Frontiers in Oncology | Thoracic Oncology

Systematic Review

Published on 02 Mar 2021

Patterns and Treatment Strategies of Osimertinib Resistance in T790M-Positive Non-Small Cell Lung Cancer: A Pooled Analysis

in Thoracic Oncology

Chunsheng Wang
Kewei Zhao
Shanliang Hu
Minghuan Li
Yipeng Song

Frontiers in Oncology

doi 10.3389/fonc.2021.600844

16,015 views
14 citations

Systematic Review

Published on 01 Mar 2021

Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis

in Thoracic Oncology

Donghui Wang
Cen Chen
Yanli Gu
Wanjun Lu
Ping Zhan
Hongbing Liu
Tangfeng Lv
Yong Song
Fang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.631949

7,750 views
67 citations

Original Research

Published on 24 Feb 2021

A CT-Based Radiomics Approach to Predict Nivolumab Response in Advanced Non-Small-Cell Lung Cancer

in Thoracic Oncology

Chang Liu
Jing Gong
Hui Yu
Quan Liu
Shengping Wang
Jialei Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.544339

7,113 views
41 citations

Original Research

Published on 23 Feb 2021

Concordance of PD-L1 Status Between Image-Guided Percutaneous Biopsies and Matched Surgical Specimen in Non-Small Cell Lung Cancer

in Thoracic Oncology

Liang Zhao
Peiqiong Chen
Kaili Fu
Jinluan Li
Yaqing Dai
Yuhuan Wang
Yanzhen Zhuang
Long Sun
Haojun Chen
Qin Lin

Frontiers in Oncology

doi 10.3389/fonc.2020.551367

3,608 views
10 citations

Systematic Review

Published on 23 Feb 2021

The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

in Thoracic Oncology

Tao Shi
Shuai Zhu
Hengjuan Guo
Xiongfei Li
Shikang Zhao
Yanye Wang
Xi Lei
Dingzhi Huang
Ling Peng
Ziming Li

Frontiers in Oncology

doi 10.3389/fonc.2021.567978

5,296 views
12 citations

Original Research

Published on 17 Feb 2021

The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer

in Thoracic Oncology

Chongya Zhai
Xiaoling Zhang
Lulu Ren
Liangkun You
Qin Pan
Hongming Pan
Weidong Han

Frontiers in Oncology

doi 10.3389/fonc.2020.619010

6,088 views
25 citations

Original Research

Published on 15 Feb 2021

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer

in Thoracic Oncology

Peng-Peng Kuang
Ning Li
Zui Liu
Tian-Yu Sun
Shu-Quan Wang
Jia Hu
Wei Ou
Si-Yu Wang

Frontiers in Oncology

doi 10.3389/fonc.2020.595650

5,904 views
36 citations

Original Research

Published on 11 Feb 2021

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

in Thoracic Oncology

Daniel Morgensztern
Manuel Cobo Dols
Santiago Ponce Aix
Pieter E. Postmus
Jaafar Bennouna
Jürgen R. Fischer
Oscar Juan-Vidal
David J. Stewart
Andrea Ardizzoni
Rafia Bhore

Frontiers in Oncology

doi 10.3389/fonc.2020.569715

6,364 views
4 citations

Original Research

Published on 08 Feb 2021

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

in Thoracic Oncology

Anna Grenda
Paweł Krawczyk
Justyna Błach
Izabela Chmielewska
Tomasz Kubiatowski
Stanisław Kieszko
Kamila Wojas-Krawczyk
Tomasz Kucharczyk
Bożena Jarosz
Iwona Paśnik

Frontiers in Oncology

doi 10.3389/fonc.2020.563613

4,937 views
18 citations

Original Research

Published on 04 Feb 2021

A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA

in Thoracic Oncology

Margaret Ottaviano
Mario Giuliano
Marianna Tortora
Evelina La Civita
Antonietta Liotti
Michele Longo
Dario Bruzzese
Michele Cennamo
Vittorio Riccio
Pietro De Placido

Frontiers in Oncology

doi 10.3389/fonc.2020.602153

3,772 views
6 citations

Editorial

Published on 03 Feb 2021

Editorial: Epigenetic Modifications in Mesothelioma

in Thoracic Oncology

Yuen Yee Cheng
Man Lee Yuen
Hongchuan Jin

Frontiers in Oncology

doi 10.3389/fonc.2021.650136

3,258 views
2 citations

Original Research

Published on 01 Feb 2021

Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients

in Thoracic Oncology

Hao Yu
Ka-On Lam
Huanmei Wu
Michael Green
Weili Wang
Jian-Yue Jin
Chen Hu
Shruti Jolly
Yang Wang
Feng-Ming Spring Kong

Frontiers in Oncology

doi 10.3389/fonc.2020.601979

4,914 views
11 citations

Original Research

Published on 28 Jan 2021

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma

in Thoracic Oncology

Jian-Zhao Xu
Chen Gong
Zheng-Fu Xie
Hua Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.593022

5,631 views
13 citations

Original Research

Published on 28 Jan 2021

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients

in Thoracic Oncology

Hang Li
Bin Li
Yunjian Pan
Yang Zhang
Jiaqing Xiang
Yawei Zhang
Yihua Sun
Xiang Yu
Wei He
Hong Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.621435

4,156 views
16 citations

Original Research

Published on 26 Jan 2021

Upregulation of Long Non-Coding RNA GCC2-AS1 Facilitates Malignant Phenotypes and Correlated With Unfavorable Prognosis for Lung Adenocarcinoma

in Thoracic Oncology

Fengqiang Yu
Mingqiang Liang
Weidong Wu
Yu Huang
Jiantao Zheng
Bin Zheng
Chun Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.628608

3,528 views
9 citations

Case Report

Published on 26 Jan 2021

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

in Thoracic Oncology

Sabine Zöchbauer-Müller
Bettina Kaserer
Helmut Prosch
Agnieszka Cseh
Flavio Solca
Markus Johann Bauer
Leonhard Müllauer

Frontiers in Oncology

doi 10.3389/fonc.2020.593852

8,128 views
19 citations

Original Research

Published on 26 Jan 2021

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

in Thoracic Oncology

Corey J. Langer
Ajeet Gajra
Cesare Gridelli
Kartik Konduri
Daniel Morgensztern
David Spigel
Denis Talbot
Michael Thomas
Jared Weiss
Richard Pilot

Frontiers in Oncology

doi 10.3389/fonc.2020.485587

7,407 views
5 citations

Original Research

Published on 25 Jan 2021

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma

in Thoracic Oncology

Wei Guo
Qilin Huai
Guochao Zhang
Lei Guo
Peng Song
Xuemin Xue
Fengwei Tan
Qi Xue
Shugeng Gao
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2020.598437

6,290 views
22 citations

Original Research

Published on 19 Jan 2021

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy

in Thoracic Oncology

Li-na He
Xuanye Zhang
Haifeng Li
Tao Chen
Chen Chen
Yixin Zhou
Zuan Lin
Wei Du
Wenfeng Fang
Yunpeng Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.621329

9,967 views
23 citations

Review

Published on 18 Jan 2021

Pulmonary Micro-Ecological Changes and Potential Microbial Markers in Lung Cancer Patients

in Thoracic Oncology

Zhuonan Ran
Jiexing Liu
Fen Wang
Caiyan Xin
Bin Xiong
Zhangyong Song

Frontiers in Oncology

doi 10.3389/fonc.2020.576855

5,749 views
13 citations

Original Research

Published on 14 Jan 2021

Protein Glycopatterns in Bronchoalveolar Lavage Fluid as Novel Potential Biomarkers for Diagnosis of Lung Cancer

in Thoracic Oncology

Lina Liu
Dan Li
Jian Shu
Li Wang
Fan Zhang
Chen Zhang
Hanjie Yu
Mingwei Chen
Zheng Li
Xuan Guo

Frontiers in Oncology

doi 10.3389/fonc.2020.568433

4,600 views
8 citations

Systematic Review

Published on 12 Jan 2021

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials

in Thoracic Oncology

Li Sun
Yi-Jia Guo
Jun Song
Yan-Ru Wang
Shu-Ling Zhang
Le-Tian Huang
Jian-Zhu Zhao
Wei Jing
Cheng-Bo Han
Jie-Tao Ma

Frontiers in Oncology

doi 10.3389/fonc.2020.586596

12,838 views
63 citations

Original Research

Published on 11 Jan 2021

Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma

in Thoracic Oncology

Lei Cai
Jiangfeng Wang
Junrong Yan
Jian Zeng
Liang Zhu
Jinxiao Liang
Chao Pan
Xiancong Huang
Ju Jin
Yang Xu

Frontiers in Oncology

doi 10.3389/fonc.2020.603671

5,878 views
18 citations

Original Research

Published on 11 Jan 2021

Predictors of CT Morphologic Features to Identify Spread Through Air Spaces Preoperatively in Small-Sized Lung Adenocarcinoma

in Thoracic Oncology

Lin Qi
Ke Xue
Yongjun Cai
Jinjuan Lu
Xiaohu Li
Ming Li

Frontiers in Oncology

doi 10.3389/fonc.2020.548430

7,543 views
37 citations

1,976 articles

articles

Patterns and Treatment Strategies of Osimertinib Resistance in T790M-Positive Non-Small Cell Lung Cancer: A Pooled Analysis

Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis

A CT-Based Radiomics Approach to Predict Nivolumab Response in Advanced Non-Small-Cell Lung Cancer

Concordance of PD-L1 Status Between Image-Guided Percutaneous Biopsies and Matched Surgical Specimen in Non-Small Cell Lung Cancer

The Impact of Programmed Death-Ligand 1 Expression on the Prognosis of Early Stage Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Literatures

The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA

Editorial: Epigenetic Modifications in Mesothelioma

Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients

Upregulation of Long Non-Coding RNA GCC2-AS1 Facilitates Malignant Phenotypes and Correlated With Unfavorable Prognosis for Lung Adenocarcinoma

Case Report: Afatinib Treatment in a Patient With NSCLC Harboring a Rare EGFR Exon 20 Mutation

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma

Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy

Pulmonary Micro-Ecological Changes and Potential Microbial Markers in Lung Cancer Patients

Protein Glycopatterns in Bronchoalveolar Lavage Fluid as Novel Potential Biomarkers for Diagnosis of Lung Cancer

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials

Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma

Predictors of CT Morphologic Features to Identify Spread Through Air Spaces Preoperatively in Small-Sized Lung Adenocarcinoma